FDA Application
-
NDC Search Results on Active Ingredient: bosentan
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
BOSENTAN | 47335-039-60 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 47335-038-64 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN ANHYDROUS | 65162-874-06 | Amneal Pharmaceuticals LLC | ANDA209742 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN ANHYDROUS | 65162-873-06 | Amneal Pharmaceuticals LLC | ANDA209742 | HUMAN PRESCRIPTION DRUG | ANDA |
BOSENTAN | 66215-102-03 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-101-03 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-101-06 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-102-06 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-103-14 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-232-56 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-103-56 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
BOSENTAN | 66215-232-14 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
1-30 | 31-42 |
-